Cargando…
Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity
Although treatment outcomes of glioblastoma, the most malignant central nervous system (CNS) tumor, has improved in the past decades, it is still incurable, and survival has only slightly improved. Advances in molecular biology and genetics have completely transformed our understanding of glioblasto...
Autores principales: | Hutóczki, Gábor, Virga, József, Birkó, Zsuzsanna, Klekner, Almos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470251/ https://www.ncbi.nlm.nih.gov/pubmed/34576168 http://dx.doi.org/10.3390/ijms221810005 |
Ejemplares similares
-
Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
por: Birkó, Zsuzsanna, et al.
Publicado: (2020) -
Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients
por: Géczi, Dóra, et al.
Publicado: (2021) -
Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity
por: Lam, K. H. Brian, et al.
Publicado: (2022) -
Extracellular matrix differences in glioblastoma patients with different prognoses
por: Virga, József, et al.
Publicado: (2019) -
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
por: Murnyák, Balázs, et al.
Publicado: (2017)